Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion type Assertion NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_head.
- NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion description "[Four apolipoprotein (apo) E variants have been reported to be associated with lipoprotein glomerulopathy (LPG), which is characterized by type III hyperlipoproteinemia (type III HLP) and proteinuria and frequently leads to nephrotic syndrome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_provenance.
- NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion evidence source_evidence_literature NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_provenance.
- NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion SIO_000772 11877595 NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_provenance.
- NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion wasDerivedFrom befree-2016 NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_provenance.
- NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_assertion wasGeneratedBy ECO_0000203 NP347191.RAvGWd1NPsFiG2_KhGgT1u8BaAnymPLG_ImnJqOfpzLtY130_provenance.